MMental health Read More ABBV Buys Rights to Bretisilocin, a Novel Psychedelic for Depression27 August 2025 AbbVie ABBV has announced a deal with private neuroscience biotech, Gilgamesh Pharmaceuticals, to acquire the latter’s lead pipeline…